rs146294483
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_013275.6(ANKRD11):c.2216C>T(p.Ser739Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000263 in 1,613,560 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_013275.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD11 | NM_013275.6 | c.2216C>T | p.Ser739Leu | missense_variant | 9/13 | ENST00000301030.10 | NP_037407.4 | |
ANKRD11 | NM_001256182.2 | c.2216C>T | p.Ser739Leu | missense_variant | 10/14 | NP_001243111.1 | ||
ANKRD11 | NM_001256183.2 | c.2216C>T | p.Ser739Leu | missense_variant | 9/13 | NP_001243112.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD11 | ENST00000301030.10 | c.2216C>T | p.Ser739Leu | missense_variant | 9/13 | 5 | NM_013275.6 | ENSP00000301030 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000790 AC: 12AN: 151816Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000200 AC: 50AN: 250566Hom.: 0 AF XY: 0.000288 AC XY: 39AN XY: 135642
GnomAD4 exome AF: 0.000283 AC: 414AN: 1461626Hom.: 0 Cov.: 38 AF XY: 0.000278 AC XY: 202AN XY: 727122
GnomAD4 genome AF: 0.0000724 AC: 11AN: 151934Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74262
ClinVar
Submissions by phenotype
KBG syndrome Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Genetics and Molecular Pathology, SA Pathology | Jan 16, 2020 | The ANKRD11 c.2216C>T variant is classified as Likely Benign (BS4, BP1) The ANKRD11 c.2216C>T variant is a single nucleotide change in the ANKRD11 gene, which is predicted to change the amino acid serine at position 739 in the protein to leucine. This variant does not segregate with disease (BS4). (paternally inherited) Disease causing variants in ANKRD11 are predominantly truncating variants and this variant is a missense variant (BP1). - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 05, 2023 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jun 23, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at